Jakub Onhajzer

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Bilirubin Ameliorates Oleic and Palmitic Acid Accumulation in an In Vitro Model of MASLD.

Bilirubin Ameliorates Oleic and Palmitic Acid Accumulation in an In Vitro Model of MASLD.

Journal: Physiological research

Published: March 11, 2026

Germline Jak2-R1063H mutation interferes with normal hematopoietic development and increases risk of thrombosis and leukemic transformation.

Germline Jak2-R1063H mutation interferes with normal hematopoietic development and increases risk of thrombosis and leukemic transformation.

Journal: Leukemia

Published: January 31, 2025

Tcf4 regulates secretory cell fate decisions in the small intestine and colon tumors: insights from transcriptomic, histological, and microbiome analyses.

Tcf4 regulates secretory cell fate decisions in the small intestine and colon tumors: insights from transcriptomic, histological, and microbiome analyses.

Journal: Stem cell research & therapy

Published: December 04, 2024

Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KRASG12D oncogene-expressing tumor cells.

Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KRASG12D oncogene-expressing tumor cells.

Journal: Transgenic research

Published: July 29, 2024

Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KrasG12D oncogene-expressing tumor cells.

Development of a new flippase-dependent mouse model for red fluorescence-based isolation of KrasG12D oncogene-expressing tumor cells.

Journal: bioRxiv : the preprint server for biology

Published: July 26, 2024

The fate of secretory cells during intestinal homeostasis, regeneration, and tumor formation is regulated by Tcf4.

The fate of secretory cells during intestinal homeostasis, regeneration, and tumor formation is regulated by Tcf4.

Journal: bioRxiv : the preprint server for biology

Published: July 19, 2024

Origin, development and therapy of colorectal cancer from the perspective of a biologist and an oncologist.

Origin, development and therapy of colorectal cancer from the perspective of a biologist and an oncologist.

Journal: Critical reviews in oncology/hematology

Published: July 18, 2024

TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial-Mesenchymal Transition and Invasiveness.

TROP2 Represents a Negative Prognostic Factor in Colorectal Adenocarcinoma and Its Expression Is Associated with Features of Epithelial-Mesenchymal Transition and Invasiveness.

Journal: Cancers

Published: July 22, 2022

Showing 1-8 of 8

Last Updated: 09/26/2026